201 results on '"Holstein, Per"'
Search Results
2. Standard complication screening information can be used for risk assessment for first time foot ulcer among patients with type 1 and type 2 diabetes
3. Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study
4. Sarcopenia and body composition in diabetic Charcot osteoarthropathy
5. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus
6. Percutaneous flexor tenotomy for preventing and treating toe ulcers in people with diabetes mellitus
7. Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy
8. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker
9. Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy
10. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy
11. Predictors of Lower-Extremity Amputation in Patients With an Infected Diabetic Foot Ulcer
12. Protection of Animals by Means of International Law. With Special Reference to the Convention for the Protection of Animals during International Transport
13. International Co-operation in the Field of Patent Law with Special Reference to the Activities of the Council of Europe
14. Additional file 2 of Risk factors for development of nephropathy in patients with a diabetic Charcot foot
15. Additional file 1 of Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case���control study
16. Additional file 3 of Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case���control study
17. Additional file 2 of Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case���control study
18. Additional file 4 of Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case���control study
19. Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study
20. Arthrodesis with external fixation in the unstable or misaligned Charcot ankle in patients with diabetes mellitus
21. Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study
22. Diabetic foot disease: impact of ulcer location on ulcer healing
23. Bone mineral density in diabetes mellitus patients with and without a Charcot foot
24. Incidence of bullosis diabeticorum – a controversial cause of chronic foot ulceration
25. Comparison of efficacy in crossing femoropopliteal artery occlusions with movable core and hydrophilic guidewires
26. Standardised method of surgical treatment of chronic leg ulcers
27. Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: A report from a pilot study
28. Decrease of Collagen Deposition in Wound Repair in Type 1 Diabetes Independent of Glycemic Control
29. A New Concept of a Multidisciplinary Wound Healing Center and a National Expert Function of Wound Healing
30. Long-Term Follow-Up in Diabetic Charcot Feet With Spontaneous Onset
31. Limb Salvage Experience in a Multidisciplinary Diabetic Foot Unit
32. MOESM2 of Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case���control study
33. Mortality and complications after treatment of acute diabetic Charcot foot
34. Uncontrolled gelatin degradation in non-healing chronic wounds
35. Late hemodynamic failure following percutaneous transluminal angioplasty for long and multifocal femorpopliteal stenoses
36. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot:An 8.5-year prospective case-control study
37. Long-term effects on the progress of neuropathy after diabetic Charcot foot:an 8.5-year prospective case-control study
38. Mortality and complications after treatment of acute diabetic Charcot foot
39. Uncontrolled gelatin degradation in non-healing chronic wounds
40. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study
41. PS10 - 47. Diabetic foot disease: impact of ulcer location on ulcer healing
42. Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers:the Eurodiale study
43. Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers – the Eurodiale study
44. High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes
45. Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer
46. Motivation, effort and life circumstances as predictors of foot ulcers and amputations in people with Type 2 diabetes mellitus
47. Den diabetiske Charcots fod
48. Sår relateret til neuropati hos diabetikere
49. Type 2-diabetes. Medicinsk teknologivurdering af screening, diagnostik og behandling:Center for Evaluering og Medicinsk Teknologivurdering
50. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.